Eugen Falk

USPTO Granted Patents = 31 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 3)

Average Co-Inventor Count = 6.0

ph-index = 8

Forward Citations = 254(Granted Patents)

Location History:

Franfurt, DE (2002)
Frankfurt-am-Main, DE (2000 - 2015)

Company Filing History:

13 out of 1,827

Sanofi-a Ventis Deutschland Gmbh

patents

10 out of 330

Aventis Pharma Deutschland, Gmbh

Hoechst Aktiengesellschaft

Years Active: 2000-2015

Loading Chart...

31 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8946212 - Annelated N-heterocyclic sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2015-02-03),

2. 8329725 - Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals (2012-12-11),

3. 8173674 - Sulfonyl-phenyl-2H-[1,2,4]oxadiazol-5-one derivatives, processes for their preparation and their use as pharmaceuticals (2012-05-08),

4. 8048901 - 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals (2011-11-01),

5. 7956077 - 2-{-3,'2-(phenyl)-oxazol-4-ylmethoxyl-cyclohexyl methoxy}-propionic acid derivatives used as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes (2011-06-07),

6. 7910612 - 4-oxy-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use (2011-03-22),

7. 7872034 - Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals (2011-01-18),

8. 7858647 - N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions thereof and methods for their therapeutic use (2010-12-28),

9. 7732471 - 6-oxazol-4-ylmetholmethoxy-alko-alkoxymethyl substituted benzoic acid derivatives forming peroxisome proliferator—activated receptor (PPAR) ligands, process for their preparation and methods of use thereof (2010-06-08),

10. 7601863 - Use of PPAR agonists for the treatment of congestive heart failure (2009-10-13),

11. 7598281 - Arylcycloakyl-substituted alkanoic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes (2009-10-06),

12. 7538131 - 2-{-3-'2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes (2009-05-26),

13. 7399777 - Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmceuticals (2008-07-15),

14. 7365084 - Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals (2008-04-29),

15. 7335671 - Arylcycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals (2008-02-26),

Title: Inventor Eugen Falk: Pioneering Innovations in Frankfurt-am-Main

Introduction: Eugen Falk is a distinguished inventor based in Frankfurt-am-Main, Germany, known for his groundbreaking contributions to various technological fields.

Latest Patents: Eugen Falk holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Eugen Falk has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Eugen Falk has collaborated with top engineers, scientists, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Eugen Falk's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

9 patents (EPO):

Please report any incorrect information to support@idiyas.com

3 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.